Short Interest in Healthcare Capital Acquisition Corp. I Rights (NASDAQ:HCACR) Expands By 156.2%

Healthcare Capital Acquisition Corp. I Rights (NASDAQ:HCACRGet Free Report) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 1,440 shares, a growth of 156.2% from the May 31st total of 562 shares. Based on an average daily volume of 108,761 shares, the short-interest ratio is presently 0.0 days.

Healthcare Capital Acquisition Corp. I Rights Stock Down 0.2%

Shares of Healthcare Capital Acquisition Corp. I Rights stock traded down $0.00 on Tuesday, hitting $0.29. The company’s stock had a trading volume of 4,500 shares, compared to its average volume of 159,079. Healthcare Capital Acquisition Corp. I Rights has a 52-week low of $0.20 and a 52-week high of $0.35. The business has a fifty day moving average of $0.31.

Healthcare Capital Acquisition Corp. I Rights (NASDAQ: HCACR) represent the rights issued in connection with Healthcare Capital Acquisition Corp., a special purpose acquisition company (SPAC) formed to effect a business combination with one or more businesses in the healthcare sector. As a blank-check company, its principal objective is to identify, negotiate and complete an acquisition, merger or similar transaction that will result in a operating public company focused on healthcare-related products and services.

The company’s primary activities are raising capital through its initial public offering and related unit structure, maintaining that capital in trust pending a qualifying business combination, and pursuing potential targets across healthcare subsectors such as pharmaceuticals, biotechnology, medical devices, healthcare services and health technology.

Featured Articles

Receive News & Ratings for Healthcare Capital Acquisition Corp. I Rights Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition Corp. I Rights and related companies with MarketBeat.com's FREE daily email newsletter.